ARCA biopharma (ABIO) said Friday its board approved a 1-for-12 reverse stock split of its shares.
The shares will start trading on a split-adjusted basis on Sept. 3 under the new name, Oruka Therapeutics, and under the new symbol "ORKA" following the expected closing of its merger with Oruka, the firm said.
Price: 4.3400, Change: +0.18, Percent Change: +4.33
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments